THE USE OF CLONIDINE IN THE TREATMENT OF NIGHTMARES AMONG PATIENTS WITH CO-MORBID PTSD AND TRAUMATIC BRAIN INJURY

被引：28
作者：
Alao, Adekola
Selvarajah, Jennifer
Razi, Syed
机构：
[1] VA Med Ctr, Syracuse, NY USA
[2] SUNY Upstate Med Univ, Dept Psychiat, Syracuse, NY 13210 USA
来源：
INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE | 2012年 / 44卷 / 02期
关键词：
clonidine; nightmares; PTSD; traumatic brain injury; norepinephrine; POSTTRAUMATIC-STRESS-DISORDER; NOREPINEPHRINE;
D O I：
10.2190/PM.44.2.g
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
Objective: To describe the successful treatment of PTSD associated nightmares in two patients with PTSD. Case Summaries: The report of the successful use of clonidine to treat PTSD associated nightmares among two Veterans following combat exposure. Discussion: Clonidine, a centrally acting alpha-agonist agent used to treat hypertension, stimulates alpha-adrenoreceptors in the brain stem. This action results in reduced sympathetic outflow from the central nervous system. We hypothesize that this central mechanism of action is why clonidine may be more effective in treating nightmares among patients with PTSD when compared with other agents. Conclusion: Clonidine should be considered as an alternative in the treatment of nightmares among patients with PTSD. (Int'l. J. Psychiatry in Medicine 2012;44:165-169)
引用
收藏
页码：165 / 169
页数：5
相关论文
共 10 条
[1]  
[Anonymous], 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425787
[2]  
Aurora RN, 2010, J CLIN SLEEP MED, V6, P389
[3]   Prazosin Versus Quetiapine for Nighttime Posttraumatic Stress Disorder Symptoms in Veterans An Assessment of Long-Term Comparative Effectiveness and Safety [J].
Byers, Melanie G. ;
Allison, Kristen M. ;
Wendel, Christopher S. ;
Lee, Jeannie K. .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 30 (03) :225-229
[4]   NORADRENERGIC ENHANCEMENT OF RECONSOLIDATION IN THE AMYGDALA IMPAIRS EXTINCTION OF CONDITIONED FEAR IN RATS-A POSSIBLE MECHANISM FOR THE PERSISTENCE OF TRAUMATIC MEMORIES IN PTSD [J].
Debiec, Jacek ;
Bush, David E. A. ;
LeDoux, Joseph E. .
DEPRESSION AND ANXIETY, 2011, 28 (03) :186-193
[5]   CSF norepinephrine concentrations in posttraumatic stress disorder [J].
Geracioti, TD ;
Baker, DG ;
Ekhator, NN ;
West, SA ;
Hill, KK ;
Bruce, AB ;
Schmidt, D ;
Rounds-Kugler, B ;
Yehuda, R ;
Keck, PE ;
Kasckow, JW .
AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (08) :1227-1230
[6]   NOCTURNAL DAYTIME URINE NORADRENERGIC MEASURES AND SLEEP IN COMBAT-RELATED PTSD [J].
MELLMAN, TA ;
KUMAR, A ;
KULICKBELL, R ;
KUMAR, M ;
NOLAN, B .
BIOLOGICAL PSYCHIATRY, 1995, 38 (03) :174-179
[7]   Neuroendocrinology of post-traumatic stress disorder [J].
Pervanidou, Panagiota ;
Chrousos, George P. .
NEUROENDOCRINOLOGY: PATHOLOGICAL SITUATIONS AND DISEASES, 2010, 182 :149-160
[8]   Conceptually driven pharmacologic approaches to acute trauma [J].
Pitman, RK ;
Delahanty, DL .
CNS SPECTRUMS, 2005, 10 (02) :99-106
[9]   Mental health impact of the Iraq and Afghanistan conflicts: A review of US research, service provision, and programmatic responses [J].
Wells, Timothy S. ;
Miller, Shannon C. ;
Adler, Amy B. ;
Engel, Charles C. ;
Smith, Tyler C. ;
Fairbank, John A. .
INTERNATIONAL REVIEW OF PSYCHIATRY, 2011, 23 (02) :144-152
[10]   Plasma norepinephrine and 3-methoxy-4-hydroxyphenylglycol concentrations and severity of depression in combat posttraumatic stress disorder and major depressive disorder [J].
Yehuda, R ;
Siever, LJ ;
Teicher, MH ;
Levengood, RA ;
Gerber, DK ;
Schmeidler, J ;
Yang, RK .
BIOLOGICAL PSYCHIATRY, 1998, 44 (01) :56-63
1